World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
55659
World Ranking
5910
National Ranking
581

Christopher J. Hawkey publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Christopher J. Hawkey sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 586 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Christopher J. Hawkey D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Christopher J. Hawkey sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 108 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Christopher J. Hawkey is affiliated with the University of Nottingham in the United Kingdom and has a research focus primarily within the field of Medicine. Their work spans multiple subfields including Surgery, Gastroenterology, Genetics, Epidemiology, and Cardiology and Cardiovascular Medicine.

The scientist has contributed to several notable topics, including:

  • Helicobacter pylori-related gastroenterology studies
  • Inflammatory Bowel Disease
  • Autoimmune and Inflammatory Disorders
  • Gastroesophageal reflux and treatments
  • Gastric Cancer Management and Outcomes
  • Autoimmune and Inflammatory Disorders Research
  • Antiplatelet Therapy and Cardiovascular Diseases

Their publication record reflects a focus on clinical trials and disease management, with frequent appearances in venues such as The Lancet, Health Technology Assessment, and The Lancet Gastroenterology & Hepatology, among others.

Recent publications by Christopher J. Hawkey include:

  • Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial, 2022, The Lancet
  • Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial, 2024, The Lancet. Gastroenterology & Hepatology
  • Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation, 2024, Health Technology Assessment
  • OFR-9 An RCT of autologous stem-cell transplantation in treatment refractory Crohn's disease (low-intensity therapy evaluation): ASTIClite, 2021, Oral
  • Eradication of Helicobacter pylori for prevention of aspirin-associated peptic ulcer bleeding in adults over 65 years: the HEAT RCT, 2025, Health Technology Assessment

Christopher J. Hawkey has collaborated frequently with colleagues including Anthony Avery, Jennifer Dumbleton, Carol Coupland, Colin Crooks, and Denise Kendrick.

Their work spans various forms of clinical research with a focus on gastrointestinal diseases, cardiovascular medicine, and inflammatory conditions. The range of publication venues and coauthors illustrates an active engagement with the medical research community in their specialized fields.

Best Publications

  • Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

    Luke Jostins;Stephan Ripke;Rinse K Weersma;Richard H Duerr

  • Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

    Claire Bombardier;Loren Laine;Alise Reicin;Deborah Shapiro

  • COX-2 inhibitors

    CJ Hawkey

  • Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease

    Katrina M de Lange;Loukas Moutsianas;James C Lee;Christopher A Lamb

  • Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials

    Colin Baigent;N. Bhala;J. Emberson;A. Merhi

  • Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.

    David Henry;Lynette L.Y. Lim;Luis A. Garcia Rodriguez;Susanne Perez Gutthann

  • Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs

    Christopher J. Hawkey;Jeffrey A. Karrasch;Leszek Szczepanski;Donald G. Walker

  • A Comparison of Omeprazole with Ranitidine for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs

    N D Yeomans;Z Tulassay;L Juhász;I Rácz

  • Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.

    Thomas J Schnitzer;Gerd R Burmester;Eduardo Mysler;Marc C Hochberg

  • Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

    Michael E. Farkouh;Howard Kirshner;Robert A. Harrington;Sean Ruland

  • European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

    R. Caprilli;M. A. Gassull;J. C. Escher;G. Moser

  • Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.

    Ali S. Taha;Nicholas Hudson;Christopher J. Hawkey;Anthony J. Swannell

  • Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.

    A. B. Hawthorne;R. F. A. Logan;C. J. Hawkey;P. N. Foster

  • Nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

    N.K. Boughton-Smith;S.M. Evans;B.J.R. Whittle;S. Moncada

  • Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

    Nicholas A Kennedy;Nicholas A Kennedy;Nicholas A Kennedy;Graham A Heap;Harry D Green;Benjamin Hamilton

  • Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease.

    W A Stack;S D Mann;A J Roy;P Heath

  • Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study

    C. J. Hawkey;Z. Tulassay;L. Szczepanski;C. J. van Rensburg

  • Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial

    Christopher Hawkey;Loren Laine;Thomas Simon;Andre Beaulieu

  • Prostaglandins and the gastrointestinal mucosa: Are they important in its function, disease, or treatment?

    C.J. Hawkey;D.S. Rampton

  • Nonsteroidal anti-inflammatory drug gastropathy

    Christopher J. Hawkey

Frequent Co-Authors

John Atherton
John Atherton Royal Brisbane and Women's Hospital
Jack Satsangi
Jack Satsangi University of Oxford
Angel Lanas
Angel Lanas University of Zaragoza
Gerhard Rogler
Gerhard Rogler University of Zurich
Roger Jones
Roger Jones King's College London
Myriam Labopin
Myriam Labopin Université Paris Cité
Nicholas J. Talley
Nicholas J. Talley University of Newcastle Australia
Simon Travis
Simon Travis University of Oxford
Loren Laine
Loren Laine Yale University
Tariq Ahmad
Tariq Ahmad Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering Medical studies in the USA opens the door to a variety of online degree options and career pathways. For those already in nursing or seeking a flexible educational route, online programs offer affordability and convenience. Many students search for the cheapest fnp programs online to become Family Nurse Practitioners, which remains a high-demand field with strong salary potential.

If you are an RN aiming to boost your credentials but need to watch your budget, exploring rn to bsn online cost comparisons can help you find wallet-friendly options. Those interested in leadership, research, or teaching roles might consider a Doctorate in Nursing Practice and look for the cheapest dnp programs.

For nurses seeking advanced practice or management, seeking out the cheapest online msn programs can be a smart move. With a range of accredited online programs now available, pursuing the next step in your healthcare career is more accessible—and affordable—than ever.

Best Scientists Citing Christopher J. Hawkey

Trending Scientists

Recently Published Articles